# Natera, Inc.: filings

NTRA · Nasdaq · CIK 1604821 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ntra.md) · [Financials](/companies/ntra/financials.md) · [Filings](/companies/ntra/filings.md) · [Insiders](/companies/ntra/insiders.md)

## Reports and events: 179 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1214, 144 223, 8-K 109, 10-Q 34, SC 13G/A 30, 3 25, 4/A 23, SC 13G 17, S-8 16, CORRESP 12, DEFA14A 12, UPLOAD 12, 10-K 11, CT ORDER 11, DEF 14A 11, 424B5 10, S-3ASR 8, S-1/A 6, SCHEDULE 13G/A 5, ARS 4, DRS/A 4, SEC STAFF LETTER 4, DRSLTR 3, 10-Q/A 2, 5 2, 8-K/A 2, EFFECT 2, S-3 2, SC 13D/A 2, SCHEDULE 13G 2, 424B4 1, 8-A12B 1, CERTNAS 1, DRS 1, FWP 1, POSASR 1, RW 1, S-1 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-07 | 20:00 ET | [10-Q](/filings/0001628280-26-054525.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054525 |
| 2026-08-06 | 16:05 ET | [8-K](/filings/0001604821-26-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001604821-26-000015 |
| 2026-07-06 | 16:05 ET | [8-K](/filings/0001604821-26-000005.md) | 5.02 Departure or appointment of officers or directors | 0001604821-26-000005 |
| 2026-06-16 | 16:08 ET | [8-K/A](/filings/0001604821-26-000004.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001604821-26-000004 |
| 2026-06-16 | 16:06 ET | [8-K](/filings/0001604821-26-000003.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001604821-26-000003 |
| 2026-06-05 | 16:08 ET | [8-K](/filings/0001604821-26-000002.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001604821-26-000002 |
| 2026-05-08 | 19:47 ET | [10-Q](/filings/0001628280-26-032478.md) | Quarterly report, period 2026-03-31 | 0001628280-26-032478 |
| 2026-05-07 | 16:10 ET | [8-K](/filings/0001628280-26-032101.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-032101 |
| 2026-04-23 | 16:44 ET | [DEF 14A](/filings/0001104659-26-047770.md) | Proxy statement, period 2026-06-11 | 0001104659-26-047770 |
| 2026-04-01 | 16:15 ET | [8-K](/filings/0001104659-26-038519.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-038519 |
| 2026-02-27 | 21:31 ET | [10-K](/filings/0001104659-26-020881.md) | Annual report, period 2025-12-31 | 0001104659-26-020881 |
| 2026-02-26 | 16:06 ET | [8-K](/filings/0001104659-26-020482.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-020482 |
| 2026-01-12 | 16:03 ET | [8-K](/filings/0001104659-26-002861.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-002861 |
| 2025-12-05 | 08:01 ET | [8-K](/filings/0001104659-25-118664.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-118664 |
| 2025-11-07 | 20:02 ET | [10-Q](/filings/0001104659-25-107976.md) | Quarterly report, period 2025-09-30 | 0001104659-25-107976 |
| 2025-11-06 | 16:08 ET | [8-K](/filings/0001104659-25-107727.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107727 |
| 2025-08-08 | 20:24 ET | [10-Q](/filings/0001558370-25-010829.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010829 |
| 2025-08-07 | 16:12 ET | [8-K](/filings/0001104659-25-075189.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-075189 |
| 2025-06-18 | 16:01 ET | [8-K](/filings/0001104659-25-060626.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-060626 |
| 2025-05-09 | 19:35 ET | [10-Q](/filings/0001558370-25-007036.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007036 |
| 2025-05-08 | 16:15 ET | [8-K](/filings/0001104659-25-046121.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-046121 |
| 2025-04-24 | 17:10 ET | [DEF 14A](/filings/0001558370-25-005445.md) | Proxy statement, period 2025-06-12 | 0001558370-25-005445 |
| 2025-03-12 | 16:05 ET | [8-K](/filings/0001104659-25-022968.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-022968 |
| 2025-02-28 | 21:43 ET | [10-K](/filings/0001558370-25-001869.md) | Annual report, period 2024-12-31 | 0001558370-25-001869 |
| 2025-02-27 | 16:10 ET | [8-K](/filings/0001104659-25-018223.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-018223 |
| 2025-01-13 | 07:05 ET | [8-K](/filings/0001104659-25-002846.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-002846 |
| 2024-12-06 | 17:00 ET | [8-K](/filings/0001104659-24-126348.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-126348 |
| 2024-11-12 | 16:23 ET | [10-Q](/filings/0001558370-24-015325.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015325 |
| 2024-11-12 | 16:10 ET | [8-K](/filings/0001104659-24-116777.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-116777 |
| 2024-08-09 | 20:28 ET | [10-Q](/filings/0001558370-24-011666.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011666 |
| 2024-08-08 | 16:11 ET | [8-K](/filings/0001104659-24-087273.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-087273 |
| 2024-07-22 | 18:34 ET | [8-K](/filings/0001104659-24-081215.md) | 8.01 Other events | 0001104659-24-081215 |
| 2024-06-18 | 16:05 ET | [8-K](/filings/0001104659-24-072800.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-072800 |
| 2024-05-10 | 20:29 ET | [10-Q](/filings/0001558370-24-007686.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007686 |
| 2024-05-09 | 16:13 ET | [8-K](/filings/0001104659-24-059333.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-059333 |
| 2024-04-24 | 16:58 ET | [DEF 14A](/filings/0001558370-24-005619.md) | Proxy statement, period 2024-06-12 | 0001558370-24-005619 |
| 2024-02-29 | 21:10 ET | [10-K](/filings/0001558370-24-002083.md) | Annual report, period 2023-12-31 | 0001558370-24-002083 |
| 2024-02-28 | 16:11 ET | [8-K](/filings/0001104659-24-028724.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-028724 |
| 2024-01-22 | 07:05 ET | [8-K](/filings/0001104659-24-005384.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-005384 |
| 2024-01-09 | 07:07 ET | [8-K](/filings/0001104659-24-002451.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-002451 |
| 2023-11-09 | 20:15 ET | [10-Q](/filings/0001558370-23-018379.md) | Quarterly report, period 2023-09-30 | 0001558370-23-018379 |
| 2023-11-08 | 16:12 ET | [8-K](/filings/0001104659-23-115735.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-115735 |
| 2023-09-07 | 17:08 ET | [8-K](/filings/0001104659-23-098990.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-098990 |
| 2023-08-04 | 19:37 ET | [10-Q](/filings/0001558370-23-013289.md) | Quarterly report, period 2023-06-30 | 0001558370-23-013289 |
| 2023-08-03 | 16:10 ET | [8-K](/filings/0001104659-23-087265.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-087265 |
| 2023-06-15 | 16:22 ET | [8-K](/filings/0001104659-23-071619.md) | 5.07 Shareholder vote results | 0001104659-23-071619 |
| 2023-05-10 | 20:46 ET | [10-Q](/filings/0001558370-23-008938.md) | Quarterly report, period 2023-03-31 | 0001558370-23-008938 |
| 2023-05-09 | 16:01 ET | [8-K](/filings/0001104659-23-057710.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-057710 |
| 2023-04-21 | 16:00 ET | [8-K](/filings/0001104659-23-048356.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-23-048356 |
| 2023-04-20 | 17:25 ET | [DEF 14A](/filings/0001558370-23-006348.md) | Proxy statement | 0001558370-23-006348 |

Page 1 of 4. [Older](/companies/ntra/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 21:35 ET. No prices; not investment advice.